Professional Documents
Culture Documents
INDUSTRY
Prepared For
Professor,
University of Dhaka
Prepared By
Md.Arafat Islam
Roll.10
University of Dhaka
0
Date of submission: December 15, 2011
Authorization Letter
We have given our maximum effort to prepare the business plan with relevant
topic that was assigned by our honorable course teacher Professor Md.Shahid
Uddin Ahmed. But there are some limitations that we had to face during making
it. We got relevant time to prepare the assignment but we couldn’t make our
report thoroughly.
In spite of having some limitations, we were sedulous to prepare the report fairly.
We hope that we will get your clemency.
1
Letter of Transmittal
December 15, 2011
Professor,
University of Dhaka
We have tried our best to put up a good plan with as much information as we could
gather during the short time span allotted for writing this business plan. We are begging
pardon for any kind of mistake.
Thank you for your kind support and help throughout the course, we remain.
2
Table of Contents
12.0 Conclusion 17
13.0 Appendix 18
3
1.0 EXECUTIVE SUMMARY
R-Tech, the first large scale pharmaceutical grade starch producer, aims to utilize a widely
available agro crop of Bangladesh, potato in order to establish a backward linkage element
of the expanding pharmaceutical industry. A major portion of the products in this sector is in
the form of tablets. And about 45%-80% of material used in tablets is starch. A market of
BDT 40.4 crore exists in Bangladesh, where there are no domestic suppliers present. For a
developing country like Bangladesh, this results in a huge import burden. Furthermore, high
price in the international arena and transport costs cause the pharmaceutical industry to
lose on the grounds of cost.
Potato is a widely grown vegetable in the country with very high starch content. Specially
the breeds grown in Bangladesh are known to have less protein and more starch making
them ideal for starch production. A starch production facility built on this will most
definitely enjoy benefits in terms of cost and quality.
R-Tech will establish a state of the art manufacturing plant at Rajshahi, one of the districts
where highest quality potato is grown in mass. The company will enter contractual farming
with farmers of the area to ensure a smooth supply of raw materials. In addition, bulk of the
required potato will be collected during the peak season when the cost is lowest. With 920
tons of initial production, the company plans to supply 15 pharmaceutical companies with
its products. Later on, the company plans to expand the production and capture 25% of the
market in 5 years of initial production.
R-Tech will target the local pharmaceutical companies and through cost leadership, the
company will be able to attain the competitive advantage. A state of the art manufacturing
facility will consistently deliver high quality product to the pharmaceutical companies on
time at a lower price. Installation of IT solution, which includes production, inventory
management, HR, accounting, and CSR modules, will help increase the overall efficiency of
the firm.
In addition, the venture will have a NPV of BDT 3,17,81,319.14 and an IRR of 24.19%. Such an
NPV and IRR indicate the bright prospect of the investment. A payback period of 4.04 years
also indicates a reasonable time by which the initial investment can be recovered.
R-Tech will pave the way to the development and expansion of backward linkage sector in
the pharmaceutical industry. Such an initiative will not only save foreign currency, but also
make the pharmaceutical industry more competitive in terms of price by supplying them
with quality raw materials, far cheaper.
4
2.0 COMPANY OVERVIEW
As the country’s first commercial pharmaceutical grade starch producer, R-Tech Public Ltd.
will produce pharmaceutical grade starch in a controlled process with all the necessary
certification for use in pharmaceutical companies in Bangladesh. The company will be using
fully automated machinery with high grade potatoes. Full control over every step of the
process will ensure production of high grade starch and cost effective production. R-Tech
will only target the domestic market consisting of 240 pharmaceutical companies.
R-Tech is starting operations with a production of 960 tons of starch using 4800 tons of
potatoes every year and within 5 years of operations, is aiming to capture 25% of the
domestic market that stands at 4000 tons per year (2010). The company will reach this goal
by increasing production by 15% annually.
There are no specific kinds of starch available. Differentiation is done based on the source of
the starch and the level of purity. There are mainly 3 sources of starch: potato, corn, and
cassava. Based on the level of purity, there are 3 grades of starch. The basic starch that we
get straight from production is called general grade starch. It is used for industrial purposes.
Food grade starch is moderately purified starch. It is used in an increasing number of food
items. Pharmacy grade is the most purified form of starch. It is widely used in
pharmaceutical products, namely in tablets. Apart from these grades, there are different
kinds of modified starch products used in different fields.
R-Tech chose pharma grade starch. The main reason behind this is the huge demand in the
domestic market. And the reason behind choosing potato as a source is the fact that it is
widely available in the local market. Furthermore, the domestically produced potato is of
the highest quality and with high starch content making it specifically suitable for starch
production.
5
4.0 MARKET ANALYSIS
4.1 DEMAND
In 2010, the total demand of pharmaceutical grade starch in Bangladesh was 4000 tons. All
of this was imported from countries like China, France, and South Korea. The use of starch
around the world is growing at a rapid rate. In today’s world, starch is one of the premier
binding and dissolving medium as well as an expedient in tablets. It constitutes about 45%
to 80% of the weight of tablets. Currently, there are 240 pharmaceutical companies
operating in Bangladesh. All of them need a substantial amount of starch every month.
Square Pharmaceuticals, the leading pharmaceutical company in Bangladesh, alone uses
about 150 tons of starch every month. Furthermore, the industry is expanding at a rate of
13%to take the advantage of patent protection by LDCs. Consequently, the industry has a
projected demand of about 4500 tons in the year 2012. This clearly shows that there is an
established market of starch in Bangladesh. In fact, the Bangladesh starch market is worth
about TK 40.8 crore per year.
R-Tech is not intending to reach the global starch market as a whole, but rather the markets
that offer the greatest value in return. That is why the company is offering only one product.
It is targeted towards the domestic pharmaceutical companies of Bangladesh. R-Tech will
not face any domestic competitors but foreign competitors.
Currently, the average price of imported pharma grade starch is TK 102,000 per ton.
Addition of import duty of 15% and other charges results in an increase in 40% over initial
pricing. Consequently, the pharmaceutical companies are importing starch at TK 102 per kg.
On the other hand, R-Tech will supply starch at TK 95 per kg. Considering a pharmaceutical
company that uses 100 ton starch annually, it is seen that the company can save TK 700,000
every year. As a result, the demand for R-Tech starch will surely be very high.
4.2 COMPETITION
4.2.1 Domestic Competitors
Though there are a number of companies operating in the starch industry in Bangladesh.
However, they only produce food grade starch. On the other hand, there is a huge market
for pharma grade starch in Bangladesh at the moment. But currently no Bangladeshi
company is operating to supply the market with pharma grade starch. Being the first
domestic supplier here, R-Tech will primarily have to compete with foreign companies.
4.2.2 Foreign Competitors
The major suppliers of pharma grade starch include China, France, and South Korea. Among
these countries, France can be considered to be the major competitor of R-Tech as it is
internationally famous for pharma grade starch. In addition, China is providing starch at a
very competitive price in the market.
4.2.3 Competitive Advantage
Cost leadership is the main competitive advantage of R-Tech. During peak seasons, the price
of potato is TK 6000 per ton, far lower than the price in the international market. Lower
6
price of raw material together with the availability of cheap labor will enable R-Tech to
produce starch at a lower cost. Therefore, R-tech will enjoy a huge advantage in final cost of
product. Consequently, R-Tech will be able to supply high quality starch at a lower price to
the pharmaceutical industry.
7
4.3.4 BRANDING
Branding will be an important element in sales promotion. As the first mover in the industry,
the company will capitalize on a brand image of consistent quality which will help R-Tech
retain its market share.
Due to high capital requirement, R-Tech is going to start out as a public limited company.
The growth prospect and the high profitability of the company will attract potential
investors. R-Tech will be authorized to issue 100,000 shares.
8
5.2 KEY OBJECTIVES
Department Objective
Production Increase production from 920 tons per year
with an annual sales growth of 15%.
Reach annual production of 1600 tons by the
end of year 5.
Sales and marketing To start selling at the end of the gestation
period
To achieve sales in the third quarter of TK
75,00,000
To achieve 25% market share in the
domestic market at the end of the 5th year
In the first step of the process, the potatoes are washed. Cleaned potatoes then slip over a
gravity chute into the potato rasp. The potatoes are converted into a mash in which the cells
are completely disrupted. This particular process liberates the starch granules. The mash is
diluted with water and then lead over a centrisieve for separation of skin fragments and cell
debris. In this step the starch milk passes through the rotating sieve while skin fragments,
which are referred to as pulp, remain on it.
Afterwards, the pulp is leached out several times in order to wash out as much starch as
possible. The obtained starch milk is still very thin. It passes on to the hydro-cyclone plant
for concentration. The plant not only serves for concentration of desired components but
also for the refining, i.e. the separation of dissolved components from the starch milk.
The concentrated and purified starch milk is then dewatered by means of a rotary vacuum
filter. In this process step a starch film disposes on the interior of a rotating and evacuated
drum and is continuously removed by a scraper knife. In the final processing step the
purified starch cake is dried by means of a flash dryer to obtain the end product: dry starch,
a white-colored powder. The starch is then packed into 25 kg bags and ready for delivery.
The total process is computer controlled. The required percentage of the components in the
starch can be preprogrammed into the central computer and with this method; a range of
9
grades can be achieved to suit individual purposes. The specifications for the
pharmaceutical grade starch will be programmed to achieve high quality product.
The potato pulp, a highly produced byproduct is vastly used in animal feed production. It is
collected during the production process and stored for the animal feed company under
contract to collect at their convenience.
The process starts on the upper left side of the image and then proceeds to bottom right.
10
7.0 SALES AND PROMOTION
As mentioned earlier, both personal selling and direct marketing will be used as modes of
selling under the marketing department. By undertaking direct marketing channel that
eliminates all the intermediaries, R-Tech will enjoy a competitive edge. Trucks will be used
to transport the starch directly to the pharmaceutical companies by road. On the other
hand, the animal feed companies will send their trucks to procure the by-product of starch.
11
sustainable, R-Tech will provide upto 25% of the price of the potatoes in advance. This will
not only help farmers buy the necessary seed and fertilizers but also help create a loyal
supplier base for R-Tech.
12
Sales & Marketing
Inauguration of promotional activities Day 110
Buyer contact & quotation Day 110-
140
Receive orders from buyer Day 120-
160
Stock ready for delivery Day 190
The major risk associated with the R-Tech is the seasonal variability of potato prices.
If the starch production is completely dependent on the availability of potatoes in
the market, it will be impossible to maintain a constant price level. In order to
minimize this risk and to ensure a consistent supply of raw material, R-Tech will
practice contractual farming with the potato growers. And a major portion of the
years raw materials will be acquired during the harvesting season.
Another major risk involved is inflation. The price at which an agreement has been
signed may change over time due to inflation. To counter this risk, a provision will be
placed in the contracts stating ranges and terms.
A backup generator along with a regulator generator will be in place to handle the
electricity crisis in the cold storage. The backup generator will be needed in the
occasion of major electricity failure. This way, R-Tech plans to minimize the spoilage
of potato due to electricity failure. In addition, 2 generators will be in place in the
manufacturing plant to ensure smooth production of starch.
In case of the occurrence of any natural disasters, 60 days stock of potatoes will
always be kept to act as a buffer.
There is also a threat of new entrants due to low entry barriers. To counter this
situation, R-Tech will emphasize on strong branding. The company plans to build up
a brand image of consistent quality.
13
In case of dissolution of R-Tech, a valuation of the business will be carried out by calculating
the market price of the assets. The payables will be resolved and the resulting gains or
losses will be shared among the stockholders.
14
10.3 CAPITAL BUDGETING INDICATORS
Capital Budgeting Indicators
Since the NPV is a large positive value, it shows that the present value of future cash flows
from R-Tech is much higher than cost of investment. Therefore, investing in R-Tech will be a
very good investment.
The payback period implies that the investors can retrieve their initial investment in just
over 4 years. This is a very reasonable period considering the large size of the investment
required in the business.
The internal rate of return (IRR) of 24.19% is reasonably higher than the required rate of
return of 16.48%. This again shows that R-Tech is a very good investment.
15
The current ratio shows that R-Tech will be successfully able to meet the short-term
obligations. Exclusion of inventories will slightly decrease the quick ratio and this may
convince the short-term creditors to provide short-term loans. R-Tech will make a profit of
37% over 1 year of operation. The debt to asset ratio shows 33% of the investment is
financed by debt, and this will have a positive image in the minds of the creditors. High
accounts receivable turnover reflects R-Tech’s strict credit policies. The high value of ROA
reflects a very efficient use of assets to generate sales. The interest coverage ratio implies
that R-Tech has a good margin of safety.
For detailed financial references please refer to appendix.
On 7th years of operation, R-Tech plans to expand and increase its production capacity to
increase its market share. New machineries, latest technologies and practices will be
incorporated in order to remain competitive in the market. Furthermore, R-Tech plans to
enter the food grade starch industry by supplying high quality starch to the food processing
industry of the country. Hence R-Tech will be gradually moving towards its vision—
developing the backward linkage sector regarding potato starch.
12.0 CONCLUSION
R-Tech will efficiently utilize the prospect of establishing a backward linkage sector in the
pharmaceutical industry through careful production, use of promotion tools and financing
to achieve an optimum mix of cost and quality using agriculture as the base. With consistent
quality and timely delivery, the company aims to pave the way for the backward linkage
industry in the field of starch in Bangladesh.
16
13.0 APPENDIX
INDEX
13.1 ASSUMPTIONS
13.2 PERSONNEL
13.3 SALES FORECAST
13.4 COST OF GOODS SOLD
13.5 INCOME STATEMENT
13.6 BALANCE SHEET
13.7 CASH FLOW STATEMENT
13.8 DEPRICIATION
13.9 LOAN AMMORTIZATION SHEDULE
13.10 RAW MATERIALS
13.11 RATIOS
17
13.1 ASSUMPTIONS
Market Growth (in KG) 13% 4,000,000.00 4,520,000.00 5,107,600.00 5,771,588.00 6,521,894.44
Market Share Growth
(initially 20% of the 15%
920,000.00 1,058,000.00 1,216,700.00 1,399,205.00 1,609,085.75
Market
Tax Holiday (7 years) 0.00% 0.00% 0.00% 0.00% 0.00%
Salary Growth 11.00% 11.00% 11.00% 11.00% 11.00%
Wastage (Optimum 7%) 10.00% 9.00% 8.00% 7.00% 7.00%
Inflation (Assumed to
10.00% 10.00% 10.00% 10.00% 10.00%
Be Steady)
Interest Rate 15.00% 15.00% 15.00% 15.00% 15.00%
Change in Currency Exchange
Rate 4.76% 4.76% 4.76% 4.76% 4.76%
Change In Price 4.00% 4.00% 4.00% 4.00% 4.00%
By Product (Almost
Equal to Mainstream 80.00% 85.00% 87.00% 90.00% 90.00%
Product)
18
13.2 PERSONNEL REQUIREMENTS
19
13.3 SALES FORECAST
20
13.5 INCOME STATEMENT
80.00
70.00
Net Income in Million BDT
60.00
50.00
40.00
30.00 Series1
20.00
10.00
-
1 2 3 4 5
Year
21
13.6 BALANCE SHEET
22
13.7 WAAC CALCULATION
23
13.9 CASH FLOW STATEMENT
24
13.10 LOAN REPAYMENT
25